KOMBINATIONSBEHANDLUNG FÜR AUGENFIBROSE UND / ODER ANGIOGENESE

Patent europeic · EP3784282 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3784282
Numer da la dumonda
EP19720551
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
26-04-2019
Publitgà
03-03-2021
Concedì
02-07-2025
La protecziun finescha il pli tard
25-04-2039
Proxima taxa annuala scadenta
30-04-2027
Classas IPC
A61K 39/395 (2006.01)
A61K 40/00 (2025.01)
A61P 43/00 (2006.01)
Prioritad
GB 201806918 27.04.2018
Dumonda PCT
PCT/EP2019/060772 26.04.2019
Publicaziun PCT
WO2019/207122 31.10.2019
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 18-05-2026

    Midada

    Published in Swissreg on 18.05.2026

  2. 01-05-2026

    Midada

    Published in Swissreg on 01.05.2026

  3. 02-07-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 02.07.2025

Partidas

Possessur

Boehringer Ingelheim International GmbH

Binger Strasse 173, 55216 Ingelheim am Rhein, DE

Inventur

COOK, Stuart Alexander

Singapore 068914, SG

SCHAEFER, Sebastian

Singapore 068914, SG

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.